Flora Peyvandi/ X
Aug 3, 2026, 11:59
Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
Flora Peyvandi, Professor of Internal Medicine at the University of Milan, shared a post on X about a recent article she and her colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy – Research and Practice in Thrombosis and Haemostasis.”
Title: Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy
Authors: Matteo Nicola Dario Di Minno, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI